Cristian Guja

16PUBLICATIONS
27CO-AUTHORS
Medical infection agents (incl. prions)Nutrigenomics and personalised nutritionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Satisfiability and optimisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 27, 2026
MASLD and Atherosclerosis in Patients with Type 2 Diabetes Mellitus: A Systematic Review.

|Mar 24, 2026
Combined Treatment of Type 2 Diabetes and Hypothyroidism: Impact of Oral Semaglutide and Levothyroxine on Cardiometabolic and Thyroid Parameters: A 6-Month Comparative Study.

Dana-Mihaela Tilici, Ruxandra-Mihaela Costinescu, Diana Loreta Paun

|Apr 30, 2024
Real-life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use.

Jochen Seufert, Nick Freemantle, Cristian Guja

|Feb 22, 2023
iGlarLixi (insulin glargine 100 U/ml plus lixisenatide) is effective and well tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real-world data.

Cristian Guja, János Tibor Kis, Martin Haluzík

|Dec 11, 2021
Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results.

Cristian Guja, Francesco Giorgino, Lawrence Blonde

|Aug 21, 2020
Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial.

Serge A Jabbour, Juan P Frías, Azazuddin Ahmed

Pageof 3

Frequent Collaborators

6 joint publications

Serge Jabbour

4 joint publications

Juan P Frías

2 joint publications

Sorin Ioacara

2 joint publications

Sorina Martin